ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership3,237,078 shares
Latest Disclosed Value $ 24,828,388
Goldman Sachs Group Inc ownership in 26CA / ImmunityBio, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 3,237,078 shares of ImmunityBio, Inc. (DE:26CA) valued at $21,235,232 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 6,152,684 shares of ImmunityBio, Inc.. This represents a change in shares of -47.39% during the quarter. The current value of the position is $19,843,288 USD.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (26CA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:26CA / ImmunityBio, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNITYBIO CMN 45256X103 3,237,078 -2,915,606 -47.39 24,828 103.81 0.0029
2026-02-10 2025-12-31 13F IMMUNITYBIO CMN 45256X103 6,152,684 5,012,001 439.39 12,182 334.14 0.0015
2025-11-14 2025-09-30 13F IMMUNITYBIO CMN 45256X103 1,140,683 309,477 37.23 2,806 27.89 0.0003
2025-08-14 2025-06-30 13F IMMUNITYBIO CMN 45256X103 831,206 -225,693 -21.35 2,194 -31.03 0.0003
2025-06-27 2025-03-31 13F/A-2 IMMUNITYBIO CMN 45256X103 1,056,899 -84,637 -7.41 3,181 8.86 0.0005
2025-05-16 2025-03-31 13F/A-1 IMMUNITYBIO CMN 45256X103 1,056,899 -84,637 3,181 0.0005
2025-05-09 2025-03-31 13F IMMUNITYBIO CMN 45256X103 1,056,899 -84,637 3,181 0.0001
2025-02-11 2024-12-31 13F IMMUNITYBIO CMN 45256X103 1,141,536 -147,371 -11.43 2,922 -39.05 0.0005
2024-11-14 2024-09-30 13F IMMUNITYBIO CMN 45256X103 1,288,907 263,932 25.75 4,795 -25.98 0.0008
2024-08-13 2024-06-30 13F IMMUNITYBIO CMN 45256X103 1,024,975 -190,406 -15.67 6,478 -0.75 0.0011
2024-05-15 2024-03-31 13F IMMUNITYBIO CMN 45256X103 1,215,381 -63,257 -4.95 6,527 1.68 0.0012
2024-05-14 2023-12-31 13F/A-2 IMMUNITYBIO CMN 45256X103 1,278,638 850,874 198.91 6,419 788.92 0.0012
2024-03-01 2023-12-31 13F/A-1 IMMUNITYBIO CMN 45256X103 1,278,638 850,874 6,419 0.0012
2024-02-13 2023-12-31 13F IMMUNITYBIO CMN 45256X103 1,278,638 850,874 6,419 0.0003
2024-05-15 2023-09-30 13F/A-1 IMMUNITYBIO CMN 45256X103 427,764 154,644 56.62 723 -4.87 0.0002
2023-11-14 2023-09-30 13F IMMUNITYBIO CMN 45256X103 427,764 154,644 723 0.0001
2024-05-14 2023-06-30 13F/A-1 IMMUNITYBIO CMN 45256X103 273,120 -80,441 -22.75 759 18.04 0.0002
2023-08-15 2023-06-30 13F IMMUNITYBIO CMN 45256X103 273,120 -80,441 759 0.0002
2024-05-14 2023-03-31 13F/A-1 IMMUNITYBIO CMN 45256X103 353,561 -798,163 -69.30 643 -88.99 0.0001
2023-05-11 2023-03-31 13F IMMUNITYBIO CMN 45256X103 353,561 -798,163 643 0.0001
2024-05-14 2022-12-31 13F/A-1 IMMUNITYBIO CMN 45256X103 1,151,724 585,881 103.54 5,839 291,850.00 0.0014
2023-02-13 2022-12-31 13F IMMUNITYBIO CMN 45256X103 1,151,724 585,881 5,839 0.0013
2024-05-14 2022-09-30 13F/A-1 IMMUNITYBIO CMN 45256X103 565,843 -4,997 -0.88 3 0.00 0.0007
2022-11-14 2022-09-30 13F IMMUNITYBIO CMN 45256X103 565,843 -4,997 2,812 0.0007
2024-05-14 2022-06-30 13F/A-2 IMMUNITYBIO CMN 45256X103 570,840 162,665 39.85 2 -99.91 0.0005
2022-08-18 2022-06-30 13F/A-1 IMMUNITYBIO CMN 45256X103 570,840 162,665 2,124 0.0005
2022-08-15 2022-06-30 13F IMMUNITYBIO CMN 45256X103 570,840 162,665 2,124 0.0005
2022-05-16 2022-03-31 13F IMMUNITYBIO CMN 45256X103 408,175 146,476 55.97 2,290 43.93 0.0005
2022-02-17 2021-12-31 13F/A-1 IMMUNITYBIO CMN 45256X103 261,699 35,952 15.93 1,591 -27.65 0.0003
2022-02-14 2021-12-31 13F IMMUNITYBIO CMN 45256X103 261,699 35,952 1,591 0.0001
2022-01-20 2021-09-30 13F/A-1 IMMUNITYBIO CMN 45256X103 225,747 29,340 14.94 2,199 -21.58 0.0005
2021-11-10 2021-09-30 13F IMMUNITYBIO CMN 45256X103 225,747 29,340 2,199 0.0005
2021-08-13 2021-06-30 13F IMMUNITYBIO CMN 45256X103 196,407 115,265 142.05 2,804 45.59 0.0006
2021-05-17 2021-03-31 13F IMMUNITYBIO CMN 45256X103 81,142 24,523 43.31 1,926 155.10 0.0005
2021-02-12 2020-12-31 13F NANTKWEST CMN 63016Q102 56,619 -1,081 -1.87 755 88.75 0.0002
2020-11-13 2020-09-30 13F NANTKWEST CMN 63016Q102 57,700 57,700 400 0.0001
2020-08-12 2020-06-30 13F NANTKWEST CMN 63016Q102 0 -80,447 -100.00 0 -100.00
2020-05-15 2020-03-31 13F NANTKWEST CMN 63016Q102 80,447 80,447 232 0.0001
2019-11-14 2019-09-30 13F NANTKWEST CMN 63016Q102 0 -77,032 -100.00 0 -100.00
2019-08-14 2019-06-30 13F NANTKWEST CMN 63016Q102 77,032 77,032 79 0.0000
2019-05-15 2019-03-31 13F NANTKWEST CMN 63016Q102 0 -78,821 -100.00 0 -100.00
2019-02-14 2018-12-31 13F NANTKWEST CMN 63016Q102 78,821 42,870 119.25 92 -30.83 0.0000
2018-11-14 2018-09-30 13F NANTKWEST CMN 63016Q102 35,951 -51,246 -58.77 133 -50.19 0.0000
2018-08-14 2018-06-30 13F NANTKWEST CMN 63016Q102 87,197 27,403 45.83 267 14.59 0.0001
2018-05-15 2018-03-31 13F NANTKWEST CMN 63016Q102 59,794 13,729 29.80 233 12.56 0.0001
2018-02-14 2017-12-31 13F NANTKWEST CMN 63016Q102 46,065 2,807 6.49 207 -12.66 0.0000
2017-11-14 2017-09-30 13F NANTKWEST CMN 63016Q102 43,258 -8,951 -17.14 237 -40.15 0.0001
2017-08-14 2017-06-30 13F NANTKWEST CMN 63016Q102 52,209 -14,908 -22.21 396 66.39 0.0001
2017-05-18 2017-03-31 13F/A-1 NANTKWEST CMN 63016Q102 67,117 348 0.52 238 -37.70 0.0001
2017-05-15 2017-03-31 13F NANTKWEST CMN 63016Q102 67,117 238
2017-02-14 2016-12-31 13F NANTKWEST CMN 63016Q102 66,769 35,811 115.68 382 58.51 0.0001
2016-11-14 2016-09-30 13F NANTKWEST CMN 63016Q102 30,958 910 3.03 241 28.88 0.0001
2016-08-15 2016-06-30 13F NANTKWEST CMN 63016Q102 30,048 -61,761 -67.27 187 -75.23 0.0001
2016-05-13 2016-03-31 13F NANTKWEST CMN 63016Q102 91,809 -136,786 -59.84 755 -80.94 0.0002
2016-02-16 2015-12-31 13F NANTKWEST CMN 63016Q102 228,595 228,595 3,962 0.0012
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-08-15 2016-06-30 13F NANTKWEST CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-13 2016-03-31 13F NANTKWEST CMN Call 50,000 0.00 411 -52.54 n/a n/a n/a
2016-02-16 2015-12-31 13F NANTKWEST CMN Call 50,000 866 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-14 2024-09-30 13F IMMUNITYBIO CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F IMMUNITYBIO CMN Put 69,300 438 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNITYBIO CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-03-01 2023-12-31 13F/A IMMUNITYBIO CMN Put 11,500 58 n/a n/a n/a
2024-05-14 2023-12-31 13F/A IMMUNITYBIO CMN Put 11,500 58 n/a n/a n/a
2024-02-13 2023-12-31 13F IMMUNITYBIO CMN Put 11,500 58 n/a n/a n/a
2016-05-13 2016-03-31 13F NANTKWEST CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F NANTKWEST CMN Put 63,300 1,097 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.